Ads
related to: new treatment for lgl leukemia in cats
Search results
Results From The WOW.Com Content Network
Recombinant feline interferon omega (RFeIFN-ω), sold under the brand name Virbagen Omega among others, is a recombinant version of a cat interferon alpha. [1] It is used to treat a range of viral diseases in cats and dogs , including canine parvovirus , feline leukemia virus (FeLV), and feline immunodeficiency virus (FIV) in many countries.
While the causes of cancer in cats are unknown, feline leukemia virus is suspected to be a prime contributor. [2] Other factors suspected to increase rates of feline cancer include toxins from the environment, passive smoking , excessive grooming, or licking parts of the body that have been in contact with an environmental toxin .
The signs and symptoms of infection with feline leukemia virus are quite varied and include loss of appetite, poor coat condition, anisocoria (uneven pupils), infections of the skin, bladder, and respiratory tract, oral disease, seizures, lymphadenopathy (swollen lymph nodes), skin lesions, fatigue, fever, weight loss, stomatitis, gingivitis, litter box avoidance, pancytopenia, recurring ...
Large granular lymphocytic (LGL) leukemia is a chronic lymphoproliferative disorder that exhibits an unexplained, chronic (> 6 months) elevation in large granular lymphocytes (LGLs) in the peripheral blood. [1] It is divided in two main categories: T-cell LGL leukemia (T-LGLL) and natural-killer (NK)-cell LGL leukemia (NK-LGLL).
A vaccine-associated sarcoma (VAS) or feline injection-site sarcoma (FISS) is a type of malignant tumor found in cats (and, often, dogs and ferrets) which has been linked to certain vaccines. VAS has become a concern for veterinarians and cat owners alike and has resulted in changes in recommended vaccine protocols.
A young leukemia patient recently received a special visit from two therapy dogs, and the sweet encounter was shared in an Instagram reel that has gone viral with nearly 10 million views. In ...
CAT intended to file an Investigational New Drug (IND) application for GCR-8015 in various CD22 positive B-cell malignancies, including Non-Hodgkin lymphoma and chronic lymphocytic leukemia, following a period of manufacturing development which is expected to be complete by the end of 2006 and to support the NCI's ongoing development of GCR ...
Feline diseases are often opportunistic and tend to be more serious in cats that already have concurrent sicknesses. Some of these can be treated and the animal can have a complete recovery. Others, like viral diseases, are more difficult to treat and cannot be treated with antibiotics, which are not effective against viruses.